// App-Quantinova.ai

FRI0280 : COMPARATIVE DRUG SURVIVAL OF TNF INHIBITORS AND SECUKINUMAB IN BIOLOGIC NAÏVE PATIENTS WITH ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS

Researchers

Presenter

  • M. Cheila

Principal Investigators

  • K. Douglas

  • C. Koutsianas

Medical Centers

  • Dudley Group of Hospitals, NS Foundation Trust, Dudley, United Kingdom, Department of Rheumatology,, Dudley, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

  • Musculoskeletal

  • Autoimmune (AI)

Disease

  • Ankylosing spondylitis

  • Psoriatic arthritis

  • Inflammatory Arthritis

Biomarkers

  • Tumor necrosis factor

Drug/Treatment

  • secukinumab

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved